Bridget F. Collins

ORCID: 0000-0003-2191-7996
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Occupational exposure and asthma
  • Medical Imaging and Pathology Studies
  • Systemic Sclerosis and Related Diseases
  • Eosinophilic Disorders and Syndromes
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Inhalation and Respiratory Drug Delivery
  • Inflammatory Myopathies and Dermatomyositis
  • Occupational and environmental lung diseases
  • Pulmonary Hypertension Research and Treatments
  • Asthma and respiratory diseases
  • Pneumonia and Respiratory Infections
  • Peroxisome Proliferator-Activated Receptors
  • Pleural and Pulmonary Diseases
  • Nutrition and Health in Aging
  • Eosinophilic Esophagitis
  • Viral-associated cancers and disorders
  • Respiratory Support and Mechanisms
  • Vascular Anomalies and Treatments
  • Respiratory and Cough-Related Research
  • Air Quality and Health Impacts
  • Tracheal and airway disorders
  • Gastroesophageal reflux and treatments
  • Virology and Viral Diseases

EvergreenHealth
2025

University of British Columbia
2024-2025

Dalhousie University
2024-2025

Memorial University of Newfoundland
2024-2025

University of Washington
2015-2024

Evergreen Health Medical Center
2024

University College Dublin
2022-2024

Pulmonary and Critical Care Associates
2023

SleepMed
2023

University of Washington Medical Center
2016-2022

Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic inflammatory fibrotic diseases. Existing ILD registries have had variable findings. Little known about the clinical profile ILDs in India.To characterize new-onset India by creating prospective using multidisciplinary discussion (MDD) to validate diagnoses.Adult patients Indian origin living with (27 centers, 19 cities, March 2012-June 2015) without malignancy or infection were included. All connective tissue (CTD)...

10.1164/rccm.201607-1484oc article EN American Journal of Respiratory and Critical Care Medicine 2016-09-29

Rationale: Current diagnosis of chronic hypersensitivity pneumonitis (cHP) involves considering a combination clinical, radiological, and pathological information in multidisciplinary team discussions. However, this approach is highly variable with poor agreement between centers.Objectives: We aimed to identify diagnostic criteria for cHP that reach consensus among international experts.Methods: A three-round modified Delphi survey was conducted April August 2017. total 45 experts...

10.1164/rccm.201710-1986oc article EN American Journal of Respiratory and Critical Care Medicine 2017-11-27
Ganesh Raghu Luca Richeldi Evans R. Fernández Pérez María Cristina De Salvo Rafael S. Silva and 95 more Jin Woo Song Takashi Ogura Zuo Jun Xu Elizabeth A. Belloli Xueping Zhang Lorilyn L. Seid Lona Poole Simon Bowler Tamera J. Corte Mark Holmes Francis Thien John Wheatley Choi Sun-Mi Man-Pyo Chung Sung-Hwan Jeong Yonghyun Kim Eunjoo Lee Hyun-Kyung Lee Choon‐Sik Park Jong Sun Park Joo Hun Park David Lam Ming-Cheng Chan Kang‐Yun Lee Jie Cao Xinguang Chen Rongchang Chen Huaping Dai Xiuhua Fu Zongan Liang Qun Luo Guochao Shi Zhaohui Tong Limin Wang Shuanying Yang Hongtao Yu Huilan Zhang Jianchu Zhang Hui Zhao Wei Wang Ying Meng Hong Peng Murali Ramaswamy Michael R. Hamblin John E. Fitzgerald Nishant Gupta Jane E. Dematte Srihari Veeraraghavan Thomas O’Brien Tracy Luckhardt Lisa Lancaster M. Kokoszynska Neil Ettinger Thomas D. Kaelin Ather Siddiqi Bridget F. Collins Mary Beth Scholand Danielle Antin‐Ozerkis Kim Hyun Christopher Harden Frank Averill Jorge M. Mallea Rebecca Bascom Vandana Seeram Amy Hajari Case E. James Britt Barry S. Shea Gerard J. Criner Mark H. Gotfried Yolanda Mageto Sherif El Bayadi Cristina Reichner Joshua J. Mooney David Hotchkin Rodeo Abrencillo R. Boente Joyce Lee Alan Betensley Niranjan Jeganathan Rajat Walia Timothy Albertson Iván O. Rosas Dileep Puppala Ladly Abraham Richard I. Enelow Nitin Bhatt Debabratra Bandyopadhyay Pedro Carlos Elias Miguel Bergna Gabriel Ricardo Garcia G. De Stefano Luis Arturo Wehbe Alejandro Chirino Ramón Luévanos Rojas María Otaola

Current treatments for idiopathic pulmonary fibrosis slow the rate of lung function decline, but may be associated with adverse events that affect medication adherence. In phase 2 trials, pamrevlumab (a fully human monoclonal antibody binds to and inhibits connective tissue growth factor activity) attenuated progression without substantial events.

10.1001/jama.2024.8693 article EN JAMA 2024-05-19
Fernando J. Martínez Eric Yow Kevin R. Flaherty Laurie D. Snyder Michael T. Durheim and 95 more Stephen R. Wisniewski Frank C. Sciurba Ganesh Raghu Maria M. Brooks Dong‐Yun Kim Daniel F. Dilling Gerard J. Criner Hyun Kim Elizabeth A. Belloli Anoop M. Nambiar Mary Beth Scholand Kevin J. Anstrom Imre Noth Rebecca Bascom Scott Beegle Nitin Bhatt Sangeeta Bhorade Sachin Chaudhary Daniel A. Culver Rick Enelow Leo C. Ginns Nishant Gupta Amy Hajari Case Michael R. Hamblin Gary M. Hunninghake Robert J. Kaner Christopher S. King Michelle Kopfinger Matthew Kottmann Lisa Lancaster David J. Lederer Tracy Luckhardt Aditi Mathur Teng Moua Justin M. Oldham Rishi Raj Shelley L. Schmidt Mary E. Strek Varsha Taskar Rade Tomic Ayodeji Adegunsoye Kareem Ahmad Rifat Ahmed Timothy Albertson Martha Alemayehu Theresa Altherr Maura Alvarez Sergio Alvarez-Mulett Michaela R. Anderson Boleyn R. Andrist Adeeb Ansari Abbas Arastu S. Aryal Deelan Ayhan Ken Baker Misbah Baqir Edwinia Battle Stacy Beasley B. Bemiss Joanna Beros Maneesh Bhargava Jason Biehl Reba Blissell Valerie Bloss Luigi Boccardi Melissa Boerman A.M. Bowser Kelsey Brait Linda Briggs Jenna Brinker Anne Brown Cameron Brown Cathy A. Brown Sean J. Callahan Jennifer Cannestra Brenna Cannon María G. Castro Ankit Choudhury Sarah Chu Chelsea Chung Karen Clark Michelle Clark Michele Cohen Bridget F. Collins Ashley Collins Molly Cope Josefina Corral Rebecca Cote A. G. O. Crowther D. Dacosta Shannon Daley Vijaya Dandamudi Priscilla Dauphin Lianne De La Cruz Mandi DeGrote

<h3>Importance</h3> Alteration in lung microbes is associated with disease progression idiopathic pulmonary fibrosis. <h3>Objective</h3> To assess the effect of antimicrobial therapy on clinical outcomes. <h3>Design, Setting, and Participants</h3> Pragmatic, randomized, unblinded trial conducted across 35 US sites. A total 513 patients older than 40 years were randomized from August 2017 to June 2019 (final follow-up was January 2020). <h3>Interventions</h3> Patients a 1:1 allocation ratio...

10.1001/jama.2021.4956 article EN JAMA 2021-05-11

We sought to assess whether laparoscopic anti-reflux surgery (LARS) is associated with decreased rates of disease progression in patients idiopathic pulmonary fibrosis (IPF).The study was a retrospective single-centre IPF worsening symptoms and function despite antacid treatment for abnormal acid gastro-oesophageal reflux. The period exposure LARS September 1998 December 2012. primary end-point longitudinal change forced vital capacity (FVC) % predicted the pre- versus post-surgery...

10.1183/13993003.00488-2016 article EN European Respiratory Journal 2016-08-04

Thiazolidinediones (TZDs) are oral antihyperglycemic medications that selective agonists to peroxisome proliferator-activated receptor gamma and have been shown potent anti-inflammatory effects in the lung.The purpose of this study was assess whether exposure TZDs is associated with a decreased risk chronic obstructive pulmonary disease (COPD) exacerbation.A cohort performed by collecting data on all US veterans diabetes COPD who were prescribed during from period October 1, 2005 September...

10.2147/copd.s82643 article EN cc-by-nc International Journal of COPD 2015-08-01

Real-time polymerase chain reaction (RT-PCR) detection of severe acute respiratory syndrome coronavirus (SARS-CoV-2) is required for diagnosis disease 2019 (COVID-19). Sensitivity RT-PCR nasopharyngeal (NP) testing presumed to be high, but there no gold standard against which this has been determined. The objective was determine whether lower tract infection (LRTI), detected in bronchoalveolar lavage fluid (BALF), occurs the absence upper with clinical both specimen types. Between March 26,...

10.1016/j.rmcr.2020.101120 article EN cc-by-nc-nd Respiratory Medicine Case Reports 2020-01-01

[Voir la version anglaise de l'article ici : www.cmaj.ca/lookup/doi/10.1503/cmaj.240947][1] Points clés Un homme blanc âgé 22 ans a consulté au service des urgences parce que depuis 2 mois, il éprouvait une fatigue croissante, douleurs abdominales intermittentes, constipation et

10.1503/cmaj.240947-f article FR cc-by-nc-nd Canadian Medical Association Journal 2025-02-09

"Questions and Answers about Measles." American Journal of Respiratory Critical Care Medicine, 0(ja), pp.

10.1164/rccm.202503-0694st article EN other-oa American Journal of Respiratory and Critical Care Medicine 2025-03-25

Thiazolidinediones are oral diabetes medications that selectively activate peroxisome proliferator-activated receptor gamma and have potent anti-inflammatory properties. While a few studies found improvements in pulmonary function with exposure to thiazolidinediones, there no of their impact on asthma exacerbations. Our objective was assess whether thiazolidinediones associated decreased risk exacerbation. We performed cohort study diabetic Veterans who had diagnosis were taking during the...

10.1186/1710-1492-10-34 article EN cc-by Allergy Asthma and Clinical Immunology 2014-07-03

Patients with idiopathic pulmonary fibrosis (IPF) experience impaired health-related quality of life (HRQoL). Several tools have been developed to objectively assess HRQoL in this patient population, but none are use routine clinical practice.To develop a rapid, specific tool that can be used for patients IPF during clinic visits.A novel and simple five-item numerical rating scale was compared two other previously validated tools. 100 consecutive managed at centre interstitial lung disease...

10.1183/13993003.00917-2021 article EN European Respiratory Journal 2021-06-10

Multiple environmental factors are associated with development of hypersensitivity pneumonitis (HP), and diagnostic algorithms for the diagnosis HP have been proposed in recent perspectives.We analyzed data patients from interstitial lung disease (ILD)-India registry. The analysis was performed to (1) find prevalence HP, (2) reclassify as per a recently classification criterion assess level certainty, (3) identify causative agents HP.This prospective multicenter study consecutive, consenting...

10.4103/lungindia.lungindia_263_19 article EN cc-by-nc-sa Lung India 2019-01-01
Coming Soon ...